查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1462912

造血幹細胞移植市場，按移植類型、按應用、按適應症、按配銷通路、最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Hematopoietic Stem Cell Transplantation Market, By Transplant Type, By Application, By Indication, By Distribution Channel, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年造血幹細胞移植市場規模為28.2312億美元，2024年至2032年複合CAGR為10.7%。

造血幹細胞移植市場-市場動態

白血病和淋巴瘤病例增加推動市場需求

由於白血病和淋巴瘤發病率的增加，預計造血幹細胞移植市場將成長更快。根據白血病和淋巴瘤協會 2019 年報告，在美國，白血病、淋巴瘤或骨髓瘤確診人數為 176,200 例，淋巴白血病和骨髓瘤患者存活率為 1,399,180 例。由於發病率上升，造血幹細胞移植（HSCT）市場預計將成長。

造血幹細胞移植市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 10.7% 左右的CAGR成長

根據移植類型細分，自體移植預計將在預測期內佔據最大的市場佔有率

根據應用細分，骨髓幹細胞移植領域預計將在預測期內佔據重要的市場佔有率

按地區分類，北美是 2023 年的主要收入來源

造血幹細胞移植市場-細分分析：

全球造血幹細胞移植市場根據移植類型應用、適應症、最終用戶、治療領域和地區進行細分。

根據移植類型，造血幹細胞移植市場分為自體、同種異體和其他。由於技術的進步、血液疾病盛行率的增加以及幹細胞療法應用的擴大，預計自體部分在預測期內將佔據最大的市場佔有率。

根據應用，造血幹細胞移植產業分為臍帶幹細胞移植、骨髓幹細胞移植、週邊幹細胞移植等。骨髓幹細胞移植領域預計將在預測期內佔據重要的市場佔有率。骨髓幹細胞移植的主要適應症包括影響骨髓的非惡性疾病和多種血液惡性腫瘤。這些疾病可能包括淋巴瘤、骨髓增生異常綜合症、再生障礙性貧血、急性和慢性白血病以及影響紅血球生成的特定遺傳性疾病。

根據指示，市場分為白血病、淋巴增殖性疾病、非惡性疾病和其他疾病。

根據配銷通路，該行業分為線下和線上。

根據最終用戶，造血幹細胞移植市場分為零售藥局、醫院藥局和專科診所。

造血幹細胞移植市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內佔據最大的市場佔有率。北美地區的市場主要受到白血病患者數量增加以及政府和私營部門研發支出增加等因素的推動。例如，加拿大癌症協會2022年5月發布的統計數據顯示，預計2022年將有6,700名加拿大人被診斷為白血病。 此外，該協會還表示，將有2,700名女性被診斷為白血病，其中1,300人將去世，4,000名男性將去世將接受白血病診斷。

造血幹細胞移植市場-競爭格局：

市場主要參與者包括輝瑞公司、Akari Therapeutics, Plc、大塚美國製藥公司、默克公司、武田製藥有限公司、Lonza、葛蘭素史克公司、諾華公司、默克公司、賽諾菲、富士膠片Holdings Corporation、bluebird bio, Inc.、Pluristem Therapeutics Inc.、Regen Biopharma Inc.、Kiadis Pharma、Taiga Biotechnologies, Inc.、CellGenix GmbH、Escape Therapeutics, Inc.、Marker Therapeutics, Inc.和Talaris Therapeutics。

最近的發展：

2022年5月，Priothera獲得美國食品藥物管理局批准，開始使用mocravimod治療接受同種異體造血幹細胞移植（HSCT）的急性髓性白血病（AML）患者的2b/3期研究。

目錄

第1章：造血幹細胞移植市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按移植類型分類的造血幹細胞移植市場片段
    • 依應用分類的造血幹細胞移植市場片段
    • 依適應症分類的造血幹細胞移植市場片段
    • 按配銷通路分類的造血幹細胞移植市場片段
    • 最終用戶的造血幹細胞移植市場片段
    • 按國家/地區分類的造血幹細胞移植市場片段
    • 按地區分類的造血幹細胞移植市場片段
  • 競爭洞察

第 3 章：造血幹細胞移植主要市場趨勢

  • 造血幹細胞移植市場促進因素
    • 市場促進因素的影響分析
  • 造血幹細胞移植市場限制
    • 市場限制影響分析
  • 造血幹細胞移植市場機會
  • 造血幹細胞移植市場未來趨勢

第4章：造血幹細胞移植產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：造血幹細胞移植市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：造血幹細胞移植市場模式

  • 2023 年造血幹細胞移植市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：造血幹細胞移植市場 - 依移植類型

  • 概述
    • 按移植類型分類的細分市場佔有率分析
    • 自體
    • 同種異體
    • 其他

第 8 章：造血幹細胞移植市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 臍帶幹細胞移植
    • 骨髓幹細胞移植
    • 週邊幹細胞移植
    • 其他

第 9 章：造血幹細胞移植市場 - 依適應症分類

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 白血病
    • 淋巴增生性疾病
    • 非惡性疾病
    • 其他

第 10 章：造血幹細胞移植市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 離線
    • 線上

第 11 章：造血幹細胞移植市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 零售藥房
    • 醫院藥房
    • 專科診所

第 12 章：造血幹細胞移植市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美造血幹細胞移植主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按移植類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按配銷通路）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲造血幹細胞移植主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按移植類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按配銷通路）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區造血幹細胞移植主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按移植類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按配銷通路）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲造血幹細胞移植主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按移植類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲造血幹細胞移植主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按移植類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第13章：主要供應商分析-造血幹細胞移植產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Akari Therapeutics, Plc
    • Otsuka America Pharmaceutical, Inc.
    • Merck KGaA
    • Takeda Pharmaceutical Company Limited
    • Lonza
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck & Co., Inc.
    • Sanofi
    • FUJIFILM Holdings Corporation
    • bluebird bio, Inc.
    • Pluristem Therapeutics Inc.
    • Regen Biopharma Inc.
    • Kiadis Pharma
    • Taiga Biotechnologies, Inc.
    • CellGenix GmbH
    • Escape Therapeutics, Inc.
    • Talaris Therapeutics
    • Marker Therapeutics, Inc.

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究應用學
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2370

REPORT HIGHLIGHT

Hematopoietic Stem Cell Transplantation Market size was valued at USD 2,823.12 Million in 2023, expanding at a CAGR of 10.7% from 2024 to 2032.

Many cancer forms and other illnesses can be treated with hematopoietic stem cell transplantation (HSCT). Two different sources of stem cells are bone marrow and blood. Hematopoietic stem cells are the young, immature blood cells found in bone marrow. The proportion of these blood cells that mature in the bone marrow and enter the bloodstream is quite low. The cells that reach the bloodstream are known as peripheral blood stem cells. After chemotherapy or radiation therapy, healthy hematopoietic stem cells are transplanted to replace absent, sick, or damaged hematopoietic stem cells.

Hematopoietic Stem Cell Transplantation Market- Market Dynamics

Increasing cases of leukemia and lymphoma to propel market demand

The market for hematopoietic stem cell transplantation is predicted to rise more rapidly due to the increased incidence of leukemia and lymphoma. In the United States, leukemia, lymphoma, or myeloma diagnosed 176,200 times, and lymph leukemia and myeloma survived in 1,399,180 cases, according to the Leukemia and Lymphoma Society's 2019 report. The market for hematopoietic stem cell transplantation (HSCT) is expected to grow as a result of the increasing incidence rate.

Hematopoietic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.7% over the forecast period (2024-2032)

Based on transplant type segmentation, the Autologous segment is expected to hold the largest market share over the forecast period

Based on application segmentation, the Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Hematopoietic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Hematopoietic Stem Cell Transplantation Market is segmented based on Transplant Type Application, Indication, End User, Therapeutic Area, and Region.

Based on the transplant type, the Hematopoietic Stem Cell Transplantation market is segmented into Autologous, Allogeneic and Others. The Autologous segment is expected to hold the largest market share over the forecast period due to advancements in technology, increased prevalence of hematological disorders, and expanding applications of stem cell therapies.

Based on the application, the Hematopoietic Stem Cell Transplantation industry is bifurcated into Cord Stem Cell Transplant, Bone Marrow Stem Cell Transplant, Peripheral Stem Cell Transplant and Others. The Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period. The main indications for bone marrow stem cell transplantation include non-malignant bone marrow-affecting diseases and a variety of hematological malignancies. These could include lymphomas, myelodysplastic syndromes, aplastic anemia, acute and chronic leukemias, and specific hereditary illnesses that impact the generation of red blood cells.

Based on the indication, the market is bifurcated into Leukemia, Lymphoproliferative Disorders, Non-Malignant Disorders and Others.

Based on the distribution channel, the industry is bifurcated into Offline and Online.

Based on the end user, the Hematopoietic Stem Cell Transplantation market is bifurcated into Retail Pharmacy, Hospital Pharmacy and Specialty Clinics.

Hematopoietic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period. The market in the North American area is primarily driven by factors such as the rising number of leukemia patients and increased governmental and private sector expenditure in research and development. For instance, statistics released in May 2022 by the Canadian Cancer Society indicates that 6,700 Canadians are anticipated to receive a leukemia diagnosis year 2022. Additionally, it stated that 2,700 women will receive a leukemia diagnosis, 1,300 of them will pass away, and 4,000 males will receive a leukemia diagnosis.

Hematopoietic Stem Cell Transplantation Market- Competitive Landscape:

The key players in the market are Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJIFILM Holdings Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

Recent Developments:

In May 2022, Priothera was granted approval by the US Food and Drug Administration to begin a Phase 2b/3 research using mocravimod in patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Akari Therapeutics, Plc

Otsuka America Pharmaceutical, Inc.

Merck KGaA

Takeda Pharmaceutical Company Limited

Lonza

GlaxoSmithKline plc

Novartis AG

Merck & Co., Inc.

Sanofi

FUJIFILM Holdings Corporation

bluebird bio, Inc.

Pluristem Therapeutics Inc.

Regen Biopharma Inc.

Kiadis Pharma

Taiga Biotechnologies, Inc.

CellGenix GmbH

Escape Therapeutics, Inc.

Talaris Therapeutics

Marker Therapeutics, Inc.

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous
  • Allogeneic
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cord Stem Cell Transplant
  • Bone Marrow Stem Cell Transplant
  • Peripheral Stem Cell Transplant
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Leukemia
  • Lymphoproliferative Disorders
  • Non-Malignant Disorders
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Offline
  • Online

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Clinics

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Hematopoietic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Hematopoietic Stem Cell Transplantation Market Snippet by Transplant Type
    • 2.1.2.Hematopoietic Stem Cell Transplantation Market Snippet by Application
    • 2.1.3.Hematopoietic Stem Cell Transplantation Market Snippet by Indication
    • 2.1.4.Hematopoietic Stem Cell Transplantation Market Snippet by Distribution Channel
    • 2.1.5.Hematopoietic Stem Cell Transplantation Market Snippet by End User
    • 2.1.6.Hematopoietic Stem Cell Transplantation Market Snippet by Country
    • 2.1.7.Hematopoietic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Hematopoietic Stem Cell Transplantation Key Market Trends

  • 3.1.Hematopoietic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Hematopoietic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Hematopoietic Stem Cell Transplantation Market Opportunities
  • 3.4.Hematopoietic Stem Cell Transplantation Market Future Trends

4.Hematopoietic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Hematopoietic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Hematopoietic Stem Cell Transplantation Market Landscape

  • 6.1.Hematopoietic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Hematopoietic Stem Cell Transplantation Market - By Transplant Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Transplant Type, 2023 & 2032 (%)
    • 7.1.2.Autologous
    • 7.1.3.Allogeneic
    • 7.1.4.Others

8.Hematopoietic Stem Cell Transplantation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cord Stem Cell Transplant
    • 8.1.3.Bone Marrow Stem Cell Transplant
    • 8.1.4.Peripheral Stem Cell Transplant
    • 8.1.5.Others

9.Hematopoietic Stem Cell Transplantation Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Leukemia
    • 9.1.3.Lymphoproliferative Disorders
    • 9.1.4.Non-Malignant Disorders
    • 9.1.5.Others

10.Hematopoietic Stem Cell Transplantation Market - By Distribution Channel

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 10.1.2.Offline
    • 10.1.3.Online

11.Hematopoietic Stem Cell Transplantation Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Retail Pharmacy
    • 11.1.3.Hospital Pharmacy
    • 11.1.4.Specialty Clinics

12.Hematopoietic Stem Cell Transplantation Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Hematopoietic Stem Cell Transplantation Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Pfizer Inc.
    • 13.2.2.Akari Therapeutics, Plc
    • 13.2.3.Otsuka America Pharmaceutical, Inc.
    • 13.2.4.Merck KGaA
    • 13.2.5.Takeda Pharmaceutical Company Limited
    • 13.2.6.Lonza
    • 13.2.7.GlaxoSmithKline plc
    • 13.2.8.Novartis AG
    • 13.2.9.Merck & Co., Inc.
    • 13.2.10.Sanofi
    • 13.2.11.FUJIFILM Holdings Corporation
    • 13.2.12.bluebird bio, Inc.
    • 13.2.13.Pluristem Therapeutics Inc.
    • 13.2.14.Regen Biopharma Inc.
    • 13.2.15.Kiadis Pharma
    • 13.2.16.Taiga Biotechnologies, Inc.
    • 13.2.17.CellGenix GmbH
    • 13.2.18.Escape Therapeutics, Inc.
    • 13.2.19.Talaris Therapeutics
    • 13.2.20.Marker Therapeutics, Inc.

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Applicationology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Usq

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hematopoietic Stem Cell Transplantation Market: Transplant Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Transplant Type
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Transplant Type 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Indication 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Hematopoietic Stem Cell Transplantation Market Segmentation
  • FIGURE Market research Indicationology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Transplant Type segment market share analysis, 2023 & 2032
  • FIGURE Transplant Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Hematopoietic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Europe Hematopoietic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Asia Pacific Hematopoietic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Latin America Hematopoietic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Middle East and Africa Hematopoietic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Hematopoietic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Germany Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Hematopoietic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE India Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Hematopoietic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Brazil Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Hematopoietic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Saudi Arabia Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Hematopoietic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)